ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
Ready to Win Big?
Try Now for Just $1!© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.
About 11.87% of NBSE shares are held by financial institutions. CARNEGIE MELLON UNIVERSITY is the top corporate investor, holding 46.97K shares valued at $40.86K. A 2.78% stake in NeuBase Therapeutics, Inc. is owned by the company. IFP ADVISORS, INC owns 0 shares valued at -, which translates its holding of 0% of the stake in the company.
Among the NBSE insiders holding of 13.38% of the stake in company, HIRSCHMAN ORIN, director, holds the largest shares of 100K. SLAKTER JASON SCOTT, Chief Executive Officer, is the second largest NBSE insider with ownership of 100K shares. RICHMAN ERIC I, director, stands third with possession of 44.96K shares of that stake.